Sagimet Biosciences, Inc. (SGMT)
9.20
+0.08
(+0.88%)
USD |
NASDAQ |
Nov 06, 10:07
Sagimet Biosciences Price to Book Value : 2.219 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 2.200 |
| November 04, 2026 | 2.410 |
| November 03, 2026 | 2.400 |
| November 02, 2026 | 2.337 |
| October 30, 2026 | 2.393 |
| October 29, 2026 | 2.516 |
| October 28, 2026 | 2.590 |
| October 27, 2026 | 2.513 |
| October 26, 2026 | 2.306 |
| October 23, 2026 | 2.311 |
| October 22, 2026 | 2.400 |
| October 21, 2026 | 2.410 |
| October 20, 2026 | 2.349 |
| October 19, 2026 | 2.137 |
| October 16, 2026 | 1.934 |
| October 15, 2026 | 1.970 |
| October 14, 2026 | 1.820 |
| October 13, 2026 | 1.925 |
| October 12, 2026 | 2.122 |
| October 09, 2026 | 2.154 |
| October 08, 2026 | 2.151 |
| October 07, 2026 | 2.142 |
| October 06, 2026 | 2.113 |
| October 05, 2026 | 2.178 |
| October 02, 2026 | 2.204 |
| Date | Value |
|---|---|
| October 01, 2026 | 2.26 |
| September 30, 2026 | 2.383 |
| September 29, 2026 | 2.250 |
| September 28, 2026 | 2.398 |
| September 25, 2026 | 2.229 |
| September 24, 2026 | 2.197 |
| September 23, 2026 | 2.513 |
| September 22, 2026 | 2.675 |
| September 21, 2026 | 2.605 |
| September 18, 2026 | 2.675 |
| September 17, 2026 | 2.694 |
| September 16, 2026 | 2.523 |
| September 15, 2026 | 2.523 |
| September 14, 2026 | 2.624 |
| September 11, 2026 | 2.624 |
| September 10, 2026 | 2.668 |
| September 09, 2026 | 2.619 |
| September 08, 2026 | 2.583 |
| September 04, 2026 | 2.639 |
| September 03, 2026 | 2.634 |
| September 02, 2026 | 2.651 |
| September 01, 2026 | 2.532 |
| August 31, 2026 | 2.475 |
| August 28, 2026 | 2.545 |
| August 27, 2026 | 2.593 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Vanda Pharmaceuticals, Inc. | 1.118 |
| IDEAYA Biosciences, Inc. | 2.722 |
| ACADIA Pharmaceuticals, Inc. | 2.757 |
| Alnylam Pharmaceuticals, Inc. | 5.846 |
| Anika Therapeutics, Inc. | 1.638 |
Price to Book Value Related Metrics
| Price | 9.20 |
| Earnings Yield | -13.93% |
| Market Cap | 568.40M |